(Total Views: 557)
Posted On: 04/02/2020 3:59:07 PM
Post# of 153889
It appears that the ban is for prophylactic use only. The drug may be used with patients suffering with COVID-19 in the FDA approved trials, Concern being that there be sufficient supply available for those using it for autoimmune and anti-malarial indications.
This action is also being taken in a number of other states, not just NY.
AMA supports this action.
Yes, providers generally have a right to use an approved medication for an off-label use but also have to be responsible about such use. Unfortunately, it appears that too many providers in NY have not been that responsible.
This action is also being taken in a number of other states, not just NY.
AMA supports this action.
Yes, providers generally have a right to use an approved medication for an off-label use but also have to be responsible about such use. Unfortunately, it appears that too many providers in NY have not been that responsible.
(1)
(0)
